buprenorphine buccal Belbuca
Selected indexed studies
- Buprenorphine buccal film for chronic pain management. (Pain Manag, 2020) [PMID:32394800]
- Economic burden and dosing trends of buprenorphine buccal film and transdermal patch in chronic low back pain. (Pain Manag, 2024) [PMID:38939964]
- Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance study. (Expert Opin Drug Saf, 2023) [PMID:37584264]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Buprenorphine buccal film for chronic pain management. (2020) pubmed
- Lixisenatide. (2017) pubmed
- Sublingual/Buccal buprenorphine and dental problems: a pharmacovigilance study. (2023) pubmed
- Economic burden and dosing trends of buprenorphine buccal film and transdermal patch in chronic low back pain. (2024) pubmed
- Buprenorphine buccal film (Belbuca) for chronic pain. (2016) pubmed
- Treatment characteristics of chronic low back pain patients treated with buprenorphine buccal film or transdermal patch. (2024) pubmed
- Converting from Transdermal to Buccal Formulations of Buprenorphine: A Pharmacokinetic Meta-Model Simulation in Healthy Volunteers. (2018) pubmed
- Low-dose Initiation of Buprenorphine in Hospitalized Patients Using Buccal Buprenorphine: A Case Series. (2023) pubmed
- Buprenorphine-naloxone buccal soluble film for the treatment of opioid dependence: current update. (2015) pubmed
- Management of moderate to severe chronic low back pain with buprenorphine buccal film using novel bioerodible mucoadhesive technology. (2016) pubmed